---
figid: PMC9214595__etm-24-01-11413-g03
pmcid: PMC9214595
image_filename: etm-24-01-11413-g03.jpg
figure_link: /pmc/articles/PMC9214595/figure/f4-ETM-24-1-11413/
number: Figure 4
figure_title: ''
caption: 'Effects of TIIA on serum levels of four liver fibrosis indicators in methionine
  choline deficiency diet-fed rats. ELISA analyses of (A) HA (NASH-F vs. control,
  P<0.001; and TIIA vs. NASH-F, P<0.001), (B) IV-C (NASH-F vs. control, P<0.001; and
  TIIA vs. NASH-F, P<0.001), (C) LN (NASH-F vs. control, P<0.001; and TIIA vs. NASH-F,
  P=0.013) and (D) PC-III (NASH-F vs. control, P<0.001; and TIIA vs. NASH-F, P<0.001).
  ##P<0.01; *P<0.05; **P<0.01 (n=6). NASH-F, non-alcoholic steatohepatitis-related
  fibrosis; TIIA, tanshinone IIA; HA, hyaluronic acid; IV-C, type Ⅳ collagen; LN,
  laminin; PC-III, type III collagen.'
article_title: Tanshinone IIA regulates the TGF-β1/Smad signaling pathway to ameliorate
  non-alcoholic steatohepatitis-related fibrosis.
citation: Lianjie Xu, et al. Exp Ther Med. 2022 Jul;24(1):486.
year: '2022'

doi: 10.3892/etm.2022.11413
journal_title: Experimental and Therapeutic Medicine
journal_nlm_ta: Exp Ther Med
publisher_name: D.A. Spandidos

keywords:
- hepatic fibrosis
- non-alcoholic steatohepatitis
- tanshinone IIA
- TGF-β1/Smad

---
